Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Analysis of Anti-CMV T-Cell Immunity and CMV Reactivation after Allogeneic Hematopoietic Cell Transplantation

George Chen, MD, Yali Zhang, MS, Joseph Dennis Tario, PhD, Amanda Herko Przespolewski, MD, Dalin Pan, Patrick Mellors, MD, Christine Ho, MD, Sophia R. Balderman, MD, Maureen Ross, MD PhD, Liselotte Brix, PhD, Paul K. Wallace, MS,PhD, Philip L. McCarthy, MD, Theresa Hahn, PhD

Blood (2017) 130 (Supplement 1): 4496.

https://doi.org/10.1182/blood.V130.Suppl_1.4496.4496

Published: 2017

Journal Articles

Effect of Immune Reconstitution on Survival after Autologous Hematopoietic Cell Transplant for B-Cell Non-Hodgkin Lymphoma

Pallawi Torka, MD, Paul K. Wallace, MS, PhD, Yali Zhang, George L. Chen, MD, Sophia R. Balderman, MD, Bruno Paiva, PhD, Christine M. Ho, MD, Maureen Ross, MD, Francisco J. Hernandez-Ilizaliturri, MD, Philip L. McCarthy, MD, Theresa Hahn, PhD

Blood (2015) 126 (23): 3173.

https://doi.org/10.1182/blood.V126.23.3173.3173

Published: 2015

Journal Articles

Short Course of Levofloxacin During Neutropenia Prevents Early and Late Bacteremia Episodes After Allogeneic Blood and Marrow Transplantation (alloBMT)

Sophia Francis, Theresa Hahn, PhD, Yali Zhang, MPH, Nikolaos Almyroudis, MD, George L. Chen, MD, Hong Liu, MD, PhD, Maureen Ross, MD, PhD, Brahm H Segal, MD, Philip L. McCarthy, Jr., MD

Blood (2012) 120 (21): 4141.

https://doi.org/10.1182/blood.V120.21.4141.4141

Published: 2012

Journal Articles

Micro Dose Methotrexate (MTX) Is Equivalent to Full Dose MTX and Superior to No MTX for Acute Graft-Versus-Host Disease Prophylaxis

George L. Chen, MD, Yali Zhang, MPH, Hong Liu, MD, PhD, Maureen Ross, MD, PhD, Theresa Hahn, PhD, Philip L. McCarthy, Jr., MD

Blood (2011) 118 (21): 3038.

https://doi.org/10.1182/blood.V118.21.3038.3038

Published: 2011

Journal Articles

Optimizing the Timing of Allogeneic Blood or Marrow Transplantation (BMT) in a Prospective Cohort of Relapsed or Refractory Acute Myeloid Leukemia (AML)

Hong Liu, MD, PhD, Yali Zhang, MPH, Theresa Hahn, PhD, Julie Thomas, DO, Meir Wetzler, MD, Eunice S. Wang, MD, Lise Hernandez, MPH, Maureen Ross, MD, PhD, George L. Chen, MD, Philip L. McCarthy, Jr., MD

Blood (2011) 118 (21): 3096.

https://doi.org/10.1182/blood.V118.21.3096.3096

Published: 2011

Journal Articles

Fludarabine, Melphalan and Low Dose Total Body Irradiation for Reduced Intensity Conditioning (RIC) Prior to Allogeneic Hematopoietic Cell Transplantation (AlloHCT)

Hong Liu, MD, PhD, Theresa Hahn, PhD, Gregory Wilding, PhD, Adrienne Groman, Barbara Bambach, MD, Meghan Higman, MD, Maureen Ross, MD, PhD, George L. Chen, MD, Philip L. McCarthy, Jr., MD

Blood (2011) 118 (21): 4570.

https://doi.org/10.1182/blood.V118.21.4570.4570

Published: 2011

NARROW

Analysis of Anti-CMV T-Cell Immunity and CMV Reactivation after Allogeneic Hematopoietic Cell Transplantation

Effect of Immune Reconstitution on Survival after Autologous Hematopoietic Cell Transplant for B-Cell Non-Hodgkin Lymphoma

Short Course of Levofloxacin During Neutropenia Prevents Early and Late Bacteremia Episodes After Allogeneic Blood and Marrow Transplantation (alloBMT)

Micro Dose Methotrexate (MTX) Is Equivalent to Full Dose MTX and Superior to No MTX for Acute Graft-Versus-Host Disease Prophylaxis

Optimizing the Timing of Allogeneic Blood or Marrow Transplantation (BMT) in a Prospective Cohort of Relapsed or Refractory Acute Myeloid Leukemia (AML)

Fludarabine, Melphalan and Low Dose Total Body Irradiation for Reduced Intensity Conditioning (RIC) Prior to Allogeneic Hematopoietic Cell Transplantation (AlloHCT)

Email alerts

ASH Publications

American Society of Hematology

Analysis of Anti-CMV T-Cell Immunity and CMV Reactivation after Allogeneic Hematopoietic Cell Transplantation

Effect of Immune Reconstitution on Survival after Autologous Hematopoietic Cell Transplant for B-Cell Non-Hodgkin Lymphoma

Short Course of Levofloxacin During Neutropenia Prevents Early and Late Bacteremia Episodes After Allogeneic Blood and Marrow Transplantation (alloBMT)

Micro Dose Methotrexate (MTX) Is Equivalent to Full Dose MTX and Superior to No MTX for Acute Graft-Versus-Host Disease Prophylaxis

Optimizing the Timing of Allogeneic Blood or Marrow Transplantation (BMT) in a Prospective Cohort of Relapsed or Refractory Acute Myeloid Leukemia (AML)

Fludarabine, Melphalan and Low Dose Total Body Irradiation for Reduced Intensity Conditioning (RIC) Prior to Allogeneic Hematopoietic Cell Transplantation (AlloHCT)

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only